AML cells are prone to fructose utilization to offset glucose insufficiency
Increased SLC2A5 transcription and fructose utilization predict poor patient outcomes
Enhanced fructose utilization exacerbates leukemic cell phenotypes
Inhibition of fructose uptake shows therapeutic potential for AML